abstract |
The present invention relates to the use of a compound of formula (I) as defined in claim 1, for the preparation of a medicament for treating or preventing pathologies corresponding to muscle degeneration of skeletal muscles, such as muscular myopathies of genetic origin, including Duchenne muscular dystrophy, or cachexia. |